Elevated Plasma Osteopontin Level is Associated with Pelvic Inflammatory Disease

Po Hui Wang, Yu Fan Liu, Hsiu Ting Tsai, Yi Torng Tee, Long Yau Lin, Yi Hsien Hsieh, Shun Fa Yang

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)


Our purpose here was to detect the association among plasma osteopontin concentration, single nucleotide polymorphisms (SNPs) of osteopontin gene, and pelvic inflammatory disease (PID). The enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) were respectively used to measure the plasma osteopontin level and its gene polymorphisms. The level of plasma osteopontin was elevated in patients with PID as compared to that of healthy women and decreased significantly after treatment. Plasma osteopontin concentration was significantly correlated with white blood cell (WBC) and neutrophil counts and plasma C-reactive protein (CRP) level in patients with PID. No significant difference was found in the genotypes or alleles distribution of osteopontin SNPs, rs1126616 or rs9138, between patients with PID and normal controls. Plasma osteopontin concentration was not associated with osteopontin polymorphism. When the cutoff level of the plasma osteopontin concentration was set to be 58.53 ng/mL, the adjusted odds ratio of plasma osteopontin for PID risk was 3.87 (95% confident interval: 1.30-11.51). Plasma osteopontin level may act as a prediction marker for PID.

Original languageEnglish
Pages (from-to)1052-1058
Number of pages7
JournalReproductive Sciences
Issue number11
Publication statusPublished - Nov 2010
Externally publishedYes


  • osteopontin
  • pelvic inflammatory disease
  • single nucleotide polymorphism

ASJC Scopus subject areas

  • Obstetrics and Gynaecology


Dive into the research topics of 'Elevated Plasma Osteopontin Level is Associated with Pelvic Inflammatory Disease'. Together they form a unique fingerprint.

Cite this